Continued Positive Results for Amyotrophic Lateral Sclerosis Phase 1/2 Trial
An amendment is being planned for an ongoing Phase 1/2 clinical trial for amyotrophic lateral sclerosis (ALS). This intention has just been announced by the cell therapy company Kadimastem. However,…